期刊文献+

金属蛋白酶组织抑制因子1在扩张型心肌病大鼠中的表达

THE EXPRESSIONS OF TIMP1 ON DOLATED CARDIOMYOPATHY RAT
下载PDF
导出
摘要 目的 :探讨金属蛋白酶组织抑制因子 1(tissue inhibitor of metalloproteinase 1,TIMP1)在扩张型心肌病大鼠中的表达。方法 :2周龄 Wistar大鼠 4 0只 ,随机分为模型组 (DCM)和空白对照组 (NC) ,每组又根据不同时间点分为 4周与 12周两个亚组。应用 RT- PCR技术检测左室心肌 TIMP1的表达活性。结果 :DCM模型组 4周与 12周亚组的 TIMP1m RNA基因表达水平明显下降 (P均 <0 .0 1) ,并且随着时间的推移 TIMP1m RNA基因表达水平下降更明显 ,至 12周时已较 4周时下降了15 0 %。结论 :DCM模型组大鼠心肌 TIMP1表达水平明显下降 。 Objective:To detect the expression of tissue inhibitor of metalloproteinase 1(TIMP1) on dilated cardiomyopathy rat.Methods:40 Wistar rat, aged two weeks, were studied randomly. All rats were divided to model group (DCM) and normal control group (NC), sub-divided to two group, 4-week sub-group, and 12-week sub group, respectively. The expressions of TIMP1 were detected by RT-PCR method.Result:The mRNA expressions of TIMP1 were increased significantly in DCM group at 4-week sub-group and 12-week sub group (P<0.01), which down regulated during developing. Up to 12-week time point, the mRNA expression of TIMP1 decreased more by 150% than in 4-week time point.Conclusion:The expressions of TIMP1 are increased significantly in DCM group which involves the left ventricular remodeling.
出处 《广西医科大学学报》 CAS 2004年第6期819-821,共3页 Journal of Guangxi Medical University
基金 广西科学研究与技术开发攻关项目基金资助 ( No.桂科攻0 3 2 2 0 2 5 -7) 广西医科大学博士后基金资助
关键词 金属蛋白酶组织抑制因子1 扩张型心肌病 细胞外基质 大鼠 matrix metalloproteinase 1 dilated cardiomyopathy extracellular matrix rat
  • 相关文献

参考文献10

  • 1Yuasa S, Nishina T, Nishimura K, et al. A rat model of dilated cardiomyopathy to investigate partial left ventriculectomy. J Card Surg, 2001,16 (1) : 40-47. 被引量:1
  • 2Czarnecki CM, Evanson OA. Distribution of myocardial glycogen in turkey poults during development of furazolidone-induced cardiomyopathy. Poult Sci, 1980,59(7):1 510-1514. 被引量:1
  • 3Spinale FG,Krombach RS,Coker ML,et al. Matrix metalloproteinase inhibition during developing congestive heart failure: effects on left ventricular geometry and function. Circ Res,1999,85(4) :364-376. 被引量:1
  • 4Pauschinger M,Chandrasekharan K,Li J,et al. Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy. Herz, 2002,27 (7): 677-682. 被引量:1
  • 5Barton PJ,Birks EJ,Felkin LE,et al. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. J Heart Lung Transplant,2003,22(7) : 738-744. 被引量:1
  • 6Schulze CJ,Wang W,Suarez-Pinzon WL,et al. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial[correction of myoctardial] ischemia-reperfusion injury.Circulation, 2003,107 (19): 2 487-2 492. 被引量:1
  • 7Li YY,Feldman AM ,Sun Y,et al. Differential expression of tissue inhibitors of metallaproteinases in the failing human heart. Circulation, 1998,98 ( 17 ): 1 728-1 734. 被引量:1
  • 8Rouet-Benzineb P, Buhler JM, Dreyfus P, et al. Altered balance between matrix gelatinases (MMP-2 and MMP- 被引量:1
  • 9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosinheavy chain degradation . Eur J Heart Fail, 1999,1 (4):337-352.9.Fedak PW, Altamentova SM, Weisel RD, et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. Am J Physiol Heart Circ Physiol, 2003,284(2) :H626-634. 被引量:1
  • 10Creemers EE, Cleutjens JP, Smits JF, et al. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res,2001, 89(3):201-210. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部